Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders

被引:31
作者
Daniil, Georgios [1 ]
Phedonos, Alexia A. P. [1 ]
Holleboom, Adriaan G. [2 ]
Motazacker, Mohammad Mandi [2 ]
Argyri, Letta [1 ]
Kuivenhoven, Jan Albert [2 ]
Chroni, Angeliki [1 ]
机构
[1] Natl Ctr Sci Res Demokritos, Inst Biol, Athens 15310, Greece
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
HDL; ApoA-I; ABCA1; LCAT; HDL antioxidant/anti-inflammatory properties; HDL subpopulations; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; FISH-EYE DISEASE; APOLIPOPROTEIN-A-I; CORONARY-ARTERY-DISEASE; LCAT DEFICIENCY; OXIDIZED PHOSPHOLIPIDS; HEART-DISEASE; LIPOPROTEINS; MUTATIONS; ABCA1;
D O I
10.1016/j.cca.2011.03.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Genetic factors regulate both high-density lipoprotein (HDL) levels and functionality, thus affecting HDL antiatherogenic properties. We characterized the HDL antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations in families with monogenic low HDL disorders. Methods: Subjects with mutations in apolipoprotein A-I (apoA-I), ATP-binding cassette transporter A1 (ABCA1) or lecithin:cholesterol acyltransferase (LCAT) and family controls were studied. HDL antioxidant/anti-inflammatory properties were assayed by an in vitro fluorometric method and HDL-associated paraoxonase-1 (PON1), platelet activating factor-acetylhydrolase (PAF-AH), LCAT, malondialdehyde (MDA), PAF and serum amyloid A (SAA) were measured. ApoA-I-containing HDL subpopulations were analyzed by two-dimensional non-denaturing gel electrophoresis. Results: ApoA-I heterozygotes and subjects with partial or complete ABCA1 or LCAT deficiency had HDL with reduced antioxidant/anti-inflammatory properties and increased MDA levels. HDL-PON1 activity was reduced in apoA-I heterozygotes and in subjects with complete ABCA1 deficiency. HDL-PAF-AH activity was reduced in subjects with partial or complete ABCA1 deficiency or complete LCAT deficiency. HDL-LCAT activity was reduced in all LCAT mutation carriers. HDL-PAF levels were increased in apoA-I heterozygotes. HDL-SAA levels were increased in subjects with complete ABCA1 deficiency. ApoA-I, ABCA1 and LCAT heterozygotes were depleted of the large alpha 1 HDL subpopulation. Subjects with complete LCAT deficiency showed mostly the small alpha 4 HDL subpopulation and subjects with complete ABCA1 deficiency the alpha 4 and pre beta HDL subpopulations. Conclusions: This study shows that mutations in apoA-I, ABCA1 and LCAT have direct effect on the antioxidant/anti-inflammatory properties of HDL Furthermore, our study shows the effect of specific mutations on the apoAI-containing HDL subpopulation profiles. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1213 / 1220
页数:8
相关论文
共 35 条
[1]
[Anonymous], CLIN CHEM
[2]
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[3]
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states [J].
Asztalos, Bela F. ;
Schaefer, Ernst J. ;
Horvath, Katalin V. ;
Yamashita, Shizuya ;
Miller, Michael ;
Franceschini, Guido ;
Calabresi, Laura .
JOURNAL OF LIPID RESEARCH, 2007, 48 (03) :592-599
[4]
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients [J].
Asztalos, BF ;
Horvath, KV ;
McNamara, JR ;
Roheim, PS ;
Rubinstein, JJ ;
Schaefer, EJ .
JOURNAL OF LIPID RESEARCH, 2002, 43 (10) :1701-1707
[5]
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial [J].
Asztalos, BF ;
Collins, D ;
Cupples, LA ;
Demissie, S ;
Horvath, KV ;
Bloomfield, HE ;
Robins, SJ ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2185-2191
[6]
Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease [J].
Asztalos, BF ;
Brousseau, ME ;
McNamara, JR ;
Horvath, KV ;
Roheim, PS ;
Schaefer, EJ .
ATHEROSCLEROSIS, 2001, 156 (01) :217-225
[7]
Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease [J].
Asztalos, BF ;
Roheim, PS ;
Milani, RL ;
Lefevre, M ;
McNamara, JR ;
Horvath, KV ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2670-2676
[8]
PREFORMED PAF-ACETHER AND LYSO PAF-ACETHER ARE BOUND TO BLOOD LIPOPROTEINS [J].
BENVENISTE, J ;
NUNEZ, D ;
DURIEZ, P ;
KORTH, R ;
BIDAULT, J ;
FRUCHART, JC .
FEBS LETTERS, 1988, 226 (02) :371-376
[9]
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes -: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families [J].
Calabresi, L ;
Pisciotta, L ;
Costantin, A ;
Frigerio, I ;
Eberini, I ;
Alessandrini, P ;
Arca, M ;
Bon, GB ;
Boscutti, G ;
Busnach, G ;
Frascà, G ;
Gesualdo, L ;
Gigante, M ;
Lupattelli, G ;
Montali, A ;
Pizzolitto, S ;
Rabbone, I ;
Rolleri, M ;
Ruotolo, G ;
Sampietro, T ;
Sessa, A ;
Vaudo, G ;
Cantafora, A ;
Veglia, F ;
Calandra, S ;
Bertolini, S ;
Franceschini, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) :1972-1978
[10]
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol [J].
Candini, C. ;
Schimmel, A. W. ;
Peter, J. ;
Bochem, A. E. ;
Holleboom, A. G. ;
Vergeer, M. ;
Dullaart, R. P. F. ;
Dallinga-Thie, G. M. ;
Hovingh, G. K. ;
Khoo, K. L. ;
Fasano, T. ;
Bocchi, L. ;
Calandra, S. ;
Kuivenhoven, J. A. ;
Motazacker, M. M. .
ATHEROSCLEROSIS, 2010, 213 (02) :492-498